The Global Health Drug Discovery Institute [GHDDI], jointly founded by the Beijing Municipal Government, the Bill & Melinda Gates Foundation and Tsinghua University, was officially launched in Beijing on March 24.
At a meeting in Davos, Switzerland on January 22, 2016, following the World Economic Forum, Tsinghua president Qiu Yong and the foundation’s co-chair Bill Gates agreed to co-found the GHDDI in Beijing and signed a memorandum of understanding.
Aside from being the first world-class non-profit global drug research institute in China, GHDDI is also the most prominent example of a high-tech Public-Private Partnership approach.
The institute aims at bringing China’s advantages in R&D into full play and conducting international drug R&D cooperation to develop new drugs for major diseases affecting the poor in developing countries.
The institute is now recruiting researchers from around the world, and has officially started developing and managing projects in multiple fields, according to Ding Sheng, director of GHDDI.
Old Version
